Showing 15 posts of 21 posts found.


AstraZeneca’s Alexion partners with Pfizer for rare disease therapies

July 28, 2023
Research and Development Alexion, AstraZeneca, Pfizer, Rare Diseases, genomics, rare disease

Alexion, AstraZeneca’s Rare Disease division, has announced that it has entered a definitive purchase and licence agreement with Pfizer. The …


Data science firm Genomics Plc names new Chief Strategy Officer

March 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genomics, pharma

Data science firm Genomics Plc, which lays claim to “the world’s largest genomic database”, has welcomed Mitchell Harris to the …


Manchester emerges as genomics research hub

May 29, 2019
Research and Development Diagnostics, Manchester, UK, genomics, pharma

­­Manchester, UK is emerging as a major hub for genomics research, according to a new firm set up in collaboration …


Top Ten most popular articles on this week!

March 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Acadia Pharmaceuticals, FDA, Sandoz, brexit, genomics, pharma, pharmacovigilance, top 10

The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …

23andMe to offer genetic reports on diabetes

March 11, 2019
Sales and Marketing 23andME, Genentech, GlaxoSmithKline, Lundbeck, diabetes, genetics, genomics

Personal genomics company, 23andMe will offer customers information on the likelihood that they are genetically predisposed to developing type 2 …


AstraZeneca to sequence genomes to develop new drugs

April 22, 2016
Medical Communications, Sales and Marketing AstraZeneca, Finland, Wellcome Trust, collaboration, genome, genomics, human longevity, institute for molecular medicine, sanger institute

AstraZeneca (LSE: AZN) has announced an integrated genomics initiative that aims to transform the drug discovery and development across is …


UK’s genomics and personalised medicine expertise showcased at major international gathering

April 8, 2016
Manufacturing and Production, Research and Development 000 genomics project, 100, NHS, UK, expertise, genomics, international gathering, world leader

The UK’s expertise in genomics was showcased at a major international gathering to foster global collaboration in this burgeoning field. …

Obama announces acceleration of Precision Medicines Initiative

February 26, 2016
Medical Communications, Research and Development Obama, Precision Medicine, cancer moonshot, genomics

A year after Barack Obama announced the $200 million Precision Medicines Initiative (PMI), the US President yesterday outlined the next …


Genomics appoints Sekar Kathiresan as scientific advisory board chair

January 11, 2016
Sales and Marketing genomics

Genomics has appointed Dr Sekar Kathiresan as chair of the company’s newly-formed scientific advisory board as chair, with immediate effect. Dr …


Berg interview: artificial intelligence and big data join the war on disease

October 13, 2015
Medical Communications, Research and Development AI, Berg, Big Data, genomics

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …


Time for pharma to think big on genomics research

October 12, 2015
Research and Development Sir John Chisholm, genomics

Sir John Chisholm, executive chair of Genomics England, is very clear about what the project he is overseeing is – …

Roche image

Roche stakes $1 billion in cancer gene research firm

January 12, 2015
Research and Development, Sales and Marketing Cancer, Foundation Medicine, Genentech, Roche, genomics, jp morgan

Roche has announced a huge billion-dollar investment in the cancer genomics research firm Foundation Medicine. Timed with the beginning of …

Merck & Co

Merck collaborates with China-based genomics specialist BGI

September 14, 2011
Research and Development BGI, Merck & Co, biomarkers, genomics

Scientists from Merck & Co and China-based genomics specialist BGI are to work together to find and develop biomarkers and …

The utility of next generation sequencing in drug development

November 3, 2010
Research and Development Dr Cheng Eng Ang, Illumina, Source BioScience, drug development, genomics, human genome, next generation sequencing

Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …

UK invests £50m in targeted research

October 13, 2010
Research and Development BIA, clinical research, genomics, personalised medicine, targeting

The government is to put more than £50 million of funding into a new initiative to produce more targeted research …

Latest content